{"nct_id":"NCT04286607","title":"Open-Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis","status":"COMPLETED","status_verified_date":"2025-01","start_date":"2020-02-12","start_date_type":"ACTUAL","primary_completion_date":"2024-01-22","primary_completion_date_type":"ACTUAL","completion_date":"2024-01-22","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["ARQT"]}